Lilly Introduces Single-Dose Vials of Zepbound, Expanding Access for Adults with Obesity

Estimated read time 1 min read

The new vials of Zepbound are available through a new self-pay pharmacy channel, priced over 50% lower than other incretin medications for obesity.

You May Also Like

More From Author

+ There are no comments

Add yours